Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-06-10

Clinical Trial Update: Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer [NA]

View source ↗

Summary

Clinical trial to screen individuals at high genetic risk for ovarian cancer, sponsored by Massachusetts General Hospital. The trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Ovarian Cancer | NA | Status: UNKNOWN